Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults

Kleiner, 2005, Design and validation of a histological scoring system for non-alcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Bedossa, 2014, Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease, Hepatology, 60, 565, 10.1002/hep.27173

Brunt, 2011, Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings, Hepatology, 53, 810, 10.1002/hep.24127

Angulo, 2013, The natural history of NAFLD, 37

Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Teli, 1995, The natural history of nonalcoholic fatty liver: a follow-up study, Hepatology, 22, 1714, 10.1002/hep.1840220616

Dam-Larsen, 2004, Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, 53, 750, 10.1136/gut.2003.019984

Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Söderberg, 2010, Decreased survival of subjects with elevated liver function tests during a 28-year follow-up, Hepatology, 51, 595, 10.1002/hep.23314

Lee, 1989, Nonalcoholic steatohepatitis: a study of 49 patients, Hum Pathol, 20, 594, 10.1016/0046-8177(89)90249-9

Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114

Evans, 2002, Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?, J Clin Pathol, 55, 689, 10.1136/jcp.55.9.689

Hashimoto, 2005, The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease, Hepatol Res, 33, 72, 10.1016/j.hepres.2005.09.007

Sanyal, 2006, Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C, Hepatology, 43, 682, 10.1002/hep.21103

Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527

Bhala, 2011, The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study, Hepatology, 54, 1208, 10.1002/hep.24491

Stepanova, 2013, Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD), Dig Dis Sci, 58, 3017, 10.1007/s10620-013-2743-5

Younossi, 2011, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality, Hepatology, 53, 1874, 10.1002/hep.24268

Angulo, 2013, Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology, 145, 782, 10.1053/j.gastro.2013.06.057

Singh, 2015, Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, 13, 643, 10.1016/j.cgh.2014.04.014

McPherson, 2015, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management, J Hepatol, 62, 1148, 10.1016/j.jhep.2014.11.034

Valenti, 2010, Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1209, 10.1002/hep.23622

Rotman, 2010, The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease, Hepatology, 52, 894, 10.1002/hep.23759

Speliotes, 2010, PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease, Hepatology, 52, 904, 10.1002/hep.23768

Valenti, 2010, I148M patatinlike phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease, Hepatology, 52, 1274, 10.1002/hep.23823

Sookoian, 2011, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease, Hepatology, 53, 1883, 10.1002/hep.24283

Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320

Sanyal, 2010, Population-based risk factors and resource utilization for HCC: US perspective, Curr Med Res Opin, 26, 2183, 10.1185/03007995.2010.506375

Yatsuji, 2009, Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C, J Gastroenterol Hepatol, 24, 248, 10.1111/j.1440-1746.2008.05640.x

Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168

Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1002/hep.1840360609

Regimbeau, 2004, Obesity and diabetes as a risk factor for hepatocellular carcinoma, Liver Transpl, 10, S69, 10.1002/lt.20033

Yasui, 2011, Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma, Clin Gastroenterol Hepatol, 9, 428, 10.1016/j.cgh.2011.01.023

Mittal, 2015, Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population, Clin Gastroenterol Hepatol, 13, 594, 10.1016/j.cgh.2014.08.013

Wong, 2014, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patient with hepatocellular carcinoma in the U.S, Hepatology, 59, 2188, 10.1002/hep.26986

Tateishi, 2015, Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study, J Gastroenterol, 50, 350, 10.1007/s00535-014-0973-8

Paradis, 2009, Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis, Hepatology, 49, 851, 10.1002/hep.22734

Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and multidisciplinary team, J Hepatol, 60, 110, 10.1016/j.jhep.2013.08.011

Leung, 2015, Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease, World J Gastroenterol, 21, 1189, 10.3748/wjg.v21.i4.1189

Tokushige, 2011, Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey, J Gastroenterol, 46, 1230, 10.1007/s00535-011-0431-9

Wong, 2012, Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography, Gut, 61, 409, 10.1136/gutjnl-2011-300342

Das, 2010, Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease, Hepatology, 51, 1593, 10.1002/hep.23567

Kwon, 2012, Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults, Am J Gastroenterol, 107, 1852, 10.1038/ajg.2012.314

Liu, 2012, Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese, J Gastroenterol Hepatol, 27, 1555, 10.1111/j.1440-1746.2012.07222.x

Wong, 2015, Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy, J Hepatol, 62, 182, 10.1016/j.jhep.2014.08.041

Younossi, 2012, Nonalcoholic fatty liver disease in lean individuals in the United States, Medicine, 91, 319, 10.1097/MD.0b013e3182779d49

Vos, 2011, Lean nonalcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease, Acta Gastroenterol Belg, 74, 389

Wong, 2010, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease, Hepatology, 51, 454, 10.1002/hep.23312

Dela Cruz, 2014, Characteristics and long-term prognosis of lean patients with non-alcoholic fatty liver disease, Gastroenterology, 146, S-909, 10.1016/S0016-5085(14)63307-2